Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/300255 stock hub

SHE/300255 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/300255is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
42.4B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/300255
In the news

Latest news · SHE/300255

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/En/a
P25 23.5P50 41.3P75 83.2
ROE-27
P25 -0.9P50 4.1P75 8.8
ROIC-6.8
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/300255 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
194
Groups with data
11
Currency
CNY
Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,194
Employees Change
-60%
Employees Change Percent
-4.78
Enterprise value
CNY 44.5B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE1000016C2
Last refreshed
2026-05-10
Market cap
CNY 42.4B
Price
CNY 46.09
Price currency
CNY
Rev Per Employee
730,764.86x
Sector
Healthcare
Sic
2834
Symbol
she/300255
Website
https://www.hbcsbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-0.84%
EV Earnings
-124.98x
EV/FCF
-294.58x
EV/Sales
50.96x
FCF yield
-0.36%
P/B ratio
36.16x
P/S ratio
48.55x
PE Ratio10 Y
41.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
-26.96%
EBITDA Margin
-19.39%
Gross margin
2.76%
Gross Profit
CNY 24.1M
Gross Profit Growth
-79.61%
Gross Profit Growth Q
5.42%
Gross Profit Growth3 Y
-70.4%
Gross Profit Growth5 Y
-57.55%
Net Income
CNY -355.8M
Net Income Growth Q
55.21%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-40.59%
Profit Margin
-40.78%
Profit Per Employee
CNY -297,996
ROA
-3.27
Roa5y
-2.78
ROCE
-11.52
ROE
-26.97
Roe5y
-17.26
ROIC
-6.8
Roic5y
-5.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
18.93%
Cagr1y
63.26%
Cagr3y
106.72%
Cagr5y
44.64%
Div CAGR10
-22.82%
Div CAGR3
-27.28%
Div CAGR5
-24.21%
EPS Growth Q
56.1
EPS Growth Quarters
1
EPS Growth Years
0
OCF Growth Q
-80.38%
Revenue Growth
-12.33x
Revenue Growth Q
-1.01x
Revenue Growth Years
0x
Revenue Growth3 Y
-27.23x
Revenue Growth5 Y
-20.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
CNY 0.19
Assets
CNY 4.4B
Cash
CNY 187.3M
Current Assets
CNY 1.8B
Current Liabilities
CNY 2.4B
Debt
CNY 2.3B
Debt Equity
CNY 1.99
Debt FCF
CNY -15.46
Equity
CNY 1.2B
Interest Coverage
-2.42
Liabilities
CNY 3.3B
Long Term Assets
CNY 2.7B
Long Term Liabilities
CNY 870.4M
Net Cash
CNY -2.1B
Net Cash By Market Cap
CNY -5.07
Net Debt Equity
CNY 1.83
Tangible Book Value
CNY 899.1M
Tangible Book Value Per Share
CNY 0.98
WACC
5.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.74
Inventory Turnover
0.69
Net Working Capital
CNY 751M
Quick ratio
0.21
Working Capital
CNY -618.6M
Working Capital Turnover
CNY -1.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
0.92%
Dividend per share
CNY 0
Last Dividend
CNY 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
466.18%
1Y total return
63.21%
200-day SMA
50.07
3Y total return
783.86%
50-day SMA
41.82
50-day SMA vs 200-day SMA
50under200
5Y total return
532.96%
All Time High
71.71
All Time High Change
-35.73%
All Time High Date
2025-11-03
All Time Low
2.03
All Time Low Change
2,167.09%
All Time Low Date
2012-01-16
ATR
2.1
Beta
0.33
Beta1y
0.64
Beta2y
0.62
Ch YTD
-25.78
High
47
High52
71.71
High52 Date
2025-11-03
High52ch
-35.73%
Low
45.81
Low52
24.56
Low52 Date
2025-05-16
Low52ch
87.66%
Ma50ch
10.22%
Price vs 200-day SMA
-7.95%
RSI
63.3
RSI Monthly
57.86
RSI Weekly
49.21
Sharpe ratio
1.38x
Sortino ratio
2.38
Total Return
0.92%
Tr YTD
-25.78
Tr1m
9.17%
Tr1w
0.26%
Tr3m
-1.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
CNY -235.2M
Operating Income Growth Q
3.6
Operating margin
-26.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
599,625,585%
Net Borrowing
82,217,538
Shares Insiders
32.22%
Shares Institutions
2.18%
Shares Out
919,060,878
Shares Qo Q
-6.55%
Shares Yo Y
-0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
CNY -151M
Average Volume
23,254,152x
Bv Per Share
1.32
CAPEX
CNY -123.8M
Ch10y
456.6
Ch1m
9.17
Ch1w
0.26
Ch1y
63.21
Ch3m
-1.2
Ch3y
783
Ch5y
529.6
Ch6m
-13.09
Change
0.48%
Change From Open
-0.48
Close
45.87
Days Gap
0.96
Depreciation Amortization
65,991,557
Dollar Volume
929,433,840.6
Earnings Date
2026-04-29
EBIT
CNY -235.2M
EBITDA
CNY -169.2M
EPS
CNY -0.39
F Score
1
FCF
CNY -151M
FCF EV Yield
-0.34x
FCF Per Share
CNY -0.16
Financing CF
38,661,468
Fiscal Year End
December
Founded
2,000
Income Tax
CNY 11.6M
Investing CF
-123,598,798
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2016-04-20
Last Split Type
Forward
Ma150
51.35
Ma150ch
-10.25%
Ma20
42.66
Ma20ch
8.04%
Net CF
-111,661,954
Open
46.31
Position In Range
23.53
Ppne
1,802,896,884
Price Date
2026-05-08
Ptbv Ratio
47.11
Relative Volume
0.87x
Revenue
872,533,244x
Tax By Revenue
1.33x
Tr6m
-13.09%
Volume
20,165,629
Z Score
7.61
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SHE/300255 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/300255 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+63.2%
S&P 500 1Y: n/a
3Y total return
+783.9%
S&P 500 3Y: n/a
5Y total return
+533.0%
S&P 500 5Y: n/a
10Y total return
+466.2%
S&P 500 10Y: n/a
Ownership

Who owns SHE/300255?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.2%
Share of float held by funds and institutions
Insider ownership
+32.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.9%
Negative means the company is buying back shares.
Technical

SHE/300255 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
63.3
Neutral momentum band
Price vs 200-day MA
-7.9%
50/200-day relationship not available
Beta (5Y)
0.33
Less volatile than the market
Sharpe ratio
1.38
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/300255

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300255 stock rating?

she/300255 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300255 analysis?

The full report lives at /stocks/she/300255/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300255?

The latest report frames she/300255 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300255 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/300255 stock profile: metrics, valuation and analysis | StockMarketAgent.AI